• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Am Heart Assoc. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting En

tetano

tetano

Editor, Senior Moderator
J Am Heart Assoc. 2020 Apr 7;9(7):e016219. doi: 10.1161/JAHA.120.016219. Epub 2020 Apr 1.
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.


Guo J[SUP]1[/SUP], Huang Z[SUP]2[/SUP], Lin L[SUP]1[/SUP], Lv J[SUP]1[/SUP].

Author information




KEYWORDS:

ACEI/ARB; COVID‐19; SARS‐CoV‐2; angiotensin‐converting enzyme 2; cardiovascular disease


PMID:32233755DOI:10.1161/JAHA.120.016219
Free full text
 
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?


Sommerstein R[SUP]1[/SUP], Kochen MM[SUP]2[/SUP], Messerli FH[SUP]3,[/SUP][SUP]4,[/SUP][SUP]5[/SUP], Gr?ni C[SUP]3[/SUP].

Author information




KEYWORDS:

ACE2; angiotensin II receptor blocker; angiotensin‐converting enzyme inhibitor; coronavirus disease 2019; epidemiology; infectious diseases


PMID:32233753DOI:10.1161/JAHA.120.016509
Free full text
 
You must log in or register to reply here.
Back
Top Bottom